Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Prescription for treating inflammatory bowel disease

An inflammatory bowel disease and prescription technology, which is applied in the field of combination formulations of traditional Chinese medicinal materials and amino acids, can solve problems such as large side effects and unsatisfactory effects, achieve good therapeutic effects, prolong human lifespan, and solve the problem of ischemia and hypoxia in the body Effect

Inactive Publication Date: 2016-02-24
何松庆
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] 1. 0.5 grams of Ganoderma lucidum, 0.6 grams of Salvia miltiorrhiza, 0.8 grams of Poria cocos, 1.2 grams of glutamine, 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cysteine ​​are made into chewing agents, 2 to 4 times a day.

[0026] 2. 0.25 grams of Ganoderma lucidum, 0.3 grams of Salvia miltiorrhiza, 0.4 grams of Poria cocos, 0.6 grams of glutamine, 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cysteine ​​are made into chewing agents, 2 to 4 times a day.

[0027] 3. Ganoderma lucidum 0.5g, Danshen 0.6g, Poria cocos 0.8g, glutamine 1.2g, threonine 0.5g, serine 0.6g, cysteine ​​0.06g are made into medicine, 2 to 4 times a day.

[0028] 4. Ganoderma lucidum 0.25g, Salvia miltiorrhiza 0.3g, Poria cocos 0.4g, glutamine 0.6g, threonine 0.25g, serine 0.3g, cysteine ​​0.03g made into medicine, 2 to 4 times a day.

[0029] 5. 5 grams of ganoderma lucidum, 6 grams of salvia miltiorrhiza, 5 grams of poria cocos, 1.2 grams of glutamine, 0.5 gra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a prescription for treating inflammatory bowel disease and belongs to the field of medicines. The prescription is prepared from lucid ganoderma, salvia miltiorrhiza, tuckahoe, glutamine, threonine, serine and cysteine; the lucid ganoderma, the salvia miltiorrhiza and the tuckahoe have effects of enhancing blood supply and oxygen supply of a human body; the glutamine is used as a main energy source of intestinal mucosa; the threonine, the serine and the cysteine are used as components of mucoprotein. The prescription disclosed by the invention provides nutrition, oxygen and raw materials for generation, renewal and repair of goblet cells and an intestinal surface mucous layer barrier formed by mucoprotein secreted by the goblet cells; the prescription has significant effects for terminating inflammation, repairing intestinal tissues and constructing a normal intestinal surface mucous layer barrier of the human body, and is an effective prescription for treating the inflammatory bowel disease.

Description

technical field [0001] The invention relates to a combined formula of Chinese medicinal materials and amino acids for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immune system and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P1/00A61K36/074A61K36/076A61K31/198
CPCA61K9/0053A61K9/0056A61K31/198A61K36/074A61K36/076A61K36/537A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products